ArticleBMC infectious diseases2025
Community-acquired pneumonia in hospitalized adults: long-term morbidities and their risk factors.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Reducing the complications from community acquired pneumonia: a review.Journal of thoracic disease · 2026Review
- Non-antimicrobial interventions in recovery from community-acquired pneumonia in adults.Current opinion in infectious diseases · 2026Review
- Risk of Noncommunicable Diseases After Hospitalization for Community-Acquired Pneumonia.Open forum infectious diseases · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe long-term morbidity associated with community-acquired pneumonia (CAP) and the risk factors associated with this long-term morbidity are unclear. In adults hospitalized for CAP, we sought to quantify the impact of CAP on loss of function, cognitive impairment, loss of employment, and quality of life six months after hospitalization for CAP and identify risk factors for these adverse outcomes.
designThis prospective cohort study is an analysis of the Pneumococcal Pneumonia Epidemiology, Urine serotyping, and Mental Outcomes (PNEUMO) study population conducted at an academic, quaternary care hospital. Patients aged ≥ 50 years old and hospitalized for CAP between 2018 and 2020 were included in this analysis. Risk factors, including demographics, pre-illness status, comorbidities, delirium at enrollment, and pneumococcal etiology, were considered. Follow-up was conducted by phone six months after hospitalization for CAP to assess basic and instrumental activities of daily living (ADL), cognition, employment, and quality of life. Proportional odds logistic regression was performed to evaluate the association between potential risk factors and long-term morbidity.
resultsOf the 296 patients included in this analysis, 12.8% lost the ability to perform at least 1 basic ADL, 22.8% lost the ability to perform at least 1 instrumental ADL, 41.6% met criteria for cognitive impairment, 58.7% had a loss of employment, and 23.6% had decreased quality of life at 6-months. Poorer pre-illness ability to perform instrumental ADLs and quality of life, lower education, female sex, former and current tobacco use, past history of dementia, and delirium were associated with worsening 6-month outcomes, with the exception of employment.
conclusionsAdult patients hospitalized for CAP suffered from significant morbidity at 6 months after discharge. Strategies are needed to prevent or mitigate these adverse outcomes, especially among those at higher risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.